Business Context and Reporting Period
Company: AE Biofuels, Inc. (formerly AE Biofuels, Inc.)
Filing Type: Form 10-K
Period Ended: December 31, 2009
AE Biofuels is an international biofuels company focused on developing and operating next-generation ethanol and biodiesel facilities. The company operates two primary segments: India, which includes a 50 million gallon per year (MGY) biodiesel plant in Kakinada, and North America, which includes a demonstration facility in Butte, Montana, and land holdings for future development. In late 2009, the company entered into a Project and Lease Agreement to acquire and retrofit a 55 MGY ethanol plant in Keyes, California, taking possession in March 2010.
Key Financial Metrics
| Metric | 2009 | 2008 |
|---|---|---|
| Net Sales | $9,175,346 | $815,655 |
| Gross Profit | $128,683 | $(1,398,709) |
| Operating Loss | $(8,756,106) | $(12,698,179) |
| Net Loss | $(11,335,452) | $(15,835,945) |
| Cash and Cash Equivalents | $52,178 | $377,905 |
| Total Debt | $15,051,493 | $10,539,766 |
| Working Capital | $(17,936,876) | $(11,347,154) |
| Stockholders' Deficit | $(3,689,688) | $4,993,807 |
Note: 2009 results include a non-cash impairment charge of $2,086,350 related to land holdings in Illinois and Nebraska.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased significantly from $815,655 in 2008 to $9.18 million in 2009, driven by expanded biodiesel sales in India and a single export shipment to Europe.
- Gross Margin Improvement: The company moved from a gross loss of $1.4 million in 2008 to a gross profit of $128,683 in 2009. This was achieved by purchasing feedstock on the spot market only when profitable margins existed, avoiding the inventory losses experienced in 2008.
- Asset Impairment: A $2.09 million impairment charge was recorded in 2009 for land assets in the North American segment due to revised cash flow estimates and debt covenant defaults.
- Debt Obligations: Total debt increased by approximately $4.5 million to $15.05 million. The company is currently in default on a term loan with the State Bank of India and had a senior secured note in default for most of 2009 (amended in December 2009).
Outlook, Risks, and Contingencies
Going Concern Uncertainty: Independent auditors have expressed substantial doubt about the company's ability to continue as a going concern. The company has a working capital deficit of $17.9 million and cash on hand sufficient for less than one month of domestic operating costs. Continued operations depend on raising additional capital and successfully restarting the Keyes, California ethanol plant.
Key Risks:
- Liquidity: The company requires significant additional working capital to fund operations, debt service, and the retrofit of the Keyes plant.
- Debt Defaults: The subsidiary in India is in default on a $4 million loan with the State Bank of India. The senior secured note with Third Eye Capital was extended to June 2010 but remains a critical liquidity risk.
- Operational Execution: There is no assurance the Keyes plant can be repaired and restarted within the projected 120 days or that the company can successfully implement its proprietary enzyme technology.
- Commodity Volatility: Margins are highly sensitive to the spread between feedstock prices (palm stearin/corn) and product prices (biodiesel/ethanol).
Legal Contingencies: The company is appealing a judgment in favor of Cordillera Fund, L.P., regarding dissenters' rights, for which a liability has been accrued. Additionally, there is pending litigation regarding the removal of restrictive legends on restricted stock held by a shareholder.
Investor Verification Checklist
- Cash Runway: Verify current cash balances and the status of the $1.6 million raised in January 2010 for the Keyes plant retrofit.
- Debt Restructuring: Confirm the status of negotiations with the State Bank of India regarding the defaulted $4 million loan and the terms of the Third Eye Capital note extension.
- Keyes Plant Status: Monitor the progress of the repair and retrofit activities at the Keyes, California facility and the timeline for commercial production.
- Capital Raises: Assess the company's ability to secure the additional equity or debt financing required to meet working capital needs and avoid liquidation.
- Asset Valuation: Review the assumptions used to value the India biodiesel facility, which comprises over 80% of total assets, given the history of operating at low capacity.